Patent · US Active

Anti-TNF-alpha-antibodies and functional fragments thereof

US12209122B2 · kind B2 · utility

0Cited by

3References

26Claims

0Family size

Assignee

Tillotts Pharma AG · CH

Inventors

Tea Gunde · Zürich, CH
Sebastian Meyer · Bielefeld, DE
Esther Maria Furrer · Rheinfelden, CH

Key dates

Filing date	Oct 3, 2022
Grant date	Jan 28, 2025
Priority date	—
Expiry date	Nov 10, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibody molecules and functional fragments thereof, capable of binding to tumor necrosis factor alpha (TNFα), to processes for their production, and to their therapeutic uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.